Infectivity of nucleic acid from highly infectious mouse scrapie brains was studied by transfecting the nucleic acid in vitro prior to inoculation into animals. Foetal mouse brain and whole mouse embryo cultures were chosen as the cells used for the transfection. As an internal control, infectious nucleic acid was recovered from bacteriophage ~X174 and whole virus particles were obtained when cultures were transfected with herpes simplex virus DNA. In contrast, none of the animals inoculated with nucleic acid preparations derived from scrapie-infected tissues developed scrapie disease either with or without transfection procedures. These findings (i) show transfection techniques fail to elicit evidence of a scrapie-specific infectious nucleic acid and (ii) confirm the observation that scrapie is not a viroid.
INTRODUCTION
The structure of the viruses of the subacute spongiform encephalopathies [kuru, Creutzfeldt-Jakob disease (CJD) and scrapie] remain elusive since purification of the membrane-associated infectivity presents great problems. Their unusual resistance to heat (Hunter & Millson, 1964; Haig & Clarke, 1965; Gibbs, 1967; Mould & Dawson, 1970) , enzyme degradation (Hunter et al., 1976; Prusiner et al., 1980b) and inactivation by u.v. and ionizing radiation (Alper et al., 1966; Gibbs et al., 1978) ; their apparent failure to induce a detectable immune response (Porter et aL, 1973; Kingsbury et aL, 1981) , cytopathological changes in cells in vitro, or its poor replication when inoculated into established tissue cultures (Clarke, 1979) , have formed the basis for their being characterized as the 'unconventional viruses'. Since several of these properties are similar to those of the plant viroids, it has been suggested that scrapie may be a viroid of animals (Diener, 1972; Malone et al., 1979) ; however, unlike the plant viroids a specific nucleic acid has not, as yet, been demonstrated for any of the unconventional viruses. Previous studies to test for the presence of infectious nucleic acid in scrapie-infected brain tissues used direct assays in animals with negative results (Marsh et al., 1974; Ward et al., 1974; Hunter et al., 1976) . In these experiments, the loss of biological activity might have been the result of rapid nucleic acid degradation upon entrance into the animal brain; early reports showed an increased DNase activity in brains of scrapie-infected mice (Millson, 1965) . A recent study by Prusiner et al. (1980a) used the acid-phenol extraction technique of Zasloff et al. (1978) for selection of closed circular DNA from scrapie-infected tissue. However, in these studies the presence of proteinase K in the preparation prior to the acid-phenol extraction may have resulted in the "~ Present address: Department of Microbiology, School of Medicine, University of California, Irvine, California 92717, U.S.A. selective loss of DNA from the aqueous phase, since Zasloff clearly stresses the need for removing all contaminating protein (Zasloff et al., 1978) .
In these studies we attempted to demonstrate scrapie infectious nucleic acid by transfection into tissue culture prior to inoculation into animals. Bacteriophage #X 174 and herpes simplex virus (HSV) were used as internal markers to monitor loss of DNA infectivity and transfection efficiency. Embryonic tissues from three different mouse strains were used as hosts for the transfection of scrapie-infected brain nucleic acid. One series of experiments utilized neuron-enriched cultures of foetal mouse brain cells. Two different transfection methods and four different nucleic acid configurations were tried. No infectious scrapie nucleic acid was found either by direct injection or by transfecting tissue culture cells with nucleic acids from scrapie brains and then assaying these cells for scrapie activity.
METHODS
Virus and bacteria. The strain of scrapie employed in these studies was the C506 isolated in mice in this laboratory from a naturally infected Cheviot sheep in 1963. The material used in these studies was from the fourth mouse brain passage (M4) in NIH general purpose Swiss-Webster female mice inoculated intracerebrally (i.c.) and sacrificed when they first showed clinical signs of scrapie. HSV-1 and herpes DNA were obtained from Dr A. Puga, NIDR. Assay for herpes, plaques was done on secondary rabbit kidney cells (SRK). Bacteriophage ~X174 virus was purchased from Miles Laboratory and its DNA was extracted in this laboratory. The bacterial strains Escheriehia coli C and KT-3, obtained from Dr E. Tessman, Department of Biology, Purdue University, were used to assay the bacteriophage and to make the spheroplasts.
Preparation of bacterial spheroplasts. A 0.5 ml amount of an overnight culture of E. eoli KT-3 was inoculated into 20 ml tryptone broth (13 g tryptone, 1 g NaC1 per 1) and placed in a shaking water bath at 37 °C. When the A650 reached 1.15, cells were centrifuged and resuspended in 0.35 ml 1.5 M-sucrose, 0.05 M-tris-HC1 pH 8.1. After very gentle shaking, 0.34 ml 30% bovine serum albumin (BSA) was added. This was followed by the addition of 0.08 ml 4% EDTA and 1 rain later 0.04 ml lysozyme at a concentration of 2 mg/ml in 0.25 M-tris-HC1 pH 8.1. After 15 min incubation at room temperature, 20 ml protoplast assay (PA) broth [10 g nutrient broth (Difco), 10 g casamino acids, 1 g glucose, 100 g sucrose per 1] was added, followed by 0-4 ml 15% MgSO 4 and protamine sulphate to a final concentration of 12 #g/ml.
~X174 infectious DNA assay. The spheroplast assay was done as follows: 0.2 ml of the spheroplast suspension was mixed with 0.2 ml of a given dilution of the sample to be assayed and the mixture incubated at 37 °C for 15 min, after which 1.6 ml PAM (PA broth plus MgSO4) was added to each tube. After gentle mixing, the sample was held at room temperature for 15 min before 0.1 ml was plated on PA agar (PA broth + 8 g/1 Difco agar) together with E. coli C as an indicator. Two spheroplast tubes were transfected per dilution and two PA agar plates per tube were used in the assay. After overnight incubation at 37 °C, clear plaques were counted, each plaque representing an infectious centre.
Mice. Swiss-Webster, Balb/c and C57B1/6 mice were obtained from the NIH colony. C57B1/6 mice used to inoculate series A experiments were purchased from Jackson Laboratories, Bar Harbor, Me., U.S.A.
Foetal brain explants.
A slight modification of the method of Ransom et al. (1977) for the preparation of spinal neuron cell cultures was employed. Pregnant C57B1/6 mice, 13 days in gestation, were sacrificed by cervical dislocation and the embryos removed. Kiliing by chloroform, ether or other anaesthesia was never used to avoid possible damage to the tissue (Ransom et al., 1977) . Foetuses were placed in sterile Petri dishes containing DISGH solution (5 % Puck's D 1 salts, 0.6 % glucose, 1.5 % sucrose, 10 mM-HEPES buffer pH 7.5); the osmolarity of the DISGH solution was measured and adjusted to 330 mosM in order to bring it to the same osmolarity as that of the nutrient to be used. One at a time, the foetuses were placed in a sterile Petri dish filled with sterile hard coloured parafilm, and the brains removed under a dissecting microscope. Brains were immediately placed in a fresh plate with DISGH and a pool of six or seven were minced and transferred by pipette to a beaker containing 10 ml DISGH plus 0.05 % trypsin. The tissue was disrupted very gently with a magnetic stirrer at 36 °C for 10 min. The supernatant was pipetted into a 15 ml centrifuge tube and after settling for a few minutes the supernatant was transferred to a tube containing 10 ml foetal calf serum. The pellets from both supernatants were pooled, new DISGH added and the stirring and settling procedure repeated twice more. The tube with the cells in foetal calf serum was centrifuged, washed and resuspended in minimal essential medium (MEM) 10/10 (80% MEM, 10% foetal calf serum, 10% horse serum) containing 0.6% glucose, no antibiotics and having an osmolarity of 330 mOSM. Cells were counted and checked for viability with trypan blue; 3 × 106 viable cells were placed on 35-mm collagen-coated dishes obtained from Dr R. Nelson, NINCDS, and 2 ml warmed media added and incubated at 36 °C for 72 h.
Nucleic acid extraction. Fifteen g of mouse brains were cut with small scissors and ground in a mortar with 5 ml of the homogenization buffer (0.1 M-NaC1, 0.01 M-tris-HC1 pH 7.4); the homogenate was transferred to a Sorvall metal cup and the mortar was washed exhaustively with the same buffer. After pooling the washings, the brain suspension was brought to 150 ml and homogenized in a Sorvall omnimixer four times for 2 min at full speed; nuclei were removed by centrifugation in an International Centrifuge at 3000 g for 15 min; the supernatant, F(1), was assayed for infectivity, divided into three portions and each one processed separately as indicated in Fig. 1 . Twenty-nine ml were used for series A, 1 ml for the control, and the remaining volume for series B; after treatment with proteinase K (100 /~g/ml) or heat inactivation, SDS was added to 1% and samples were mixed with 1 vol. of the organic solvents shown in Fig. 1 . Aqueous phases and interfaces were reextracted with 1 vol. of chloroform, and, after pooling, they were made 0.3 M-NaC1 before precipitation with 2 vol. cold ethanol for 18 h at -20 °C. Pellets were obtained by centrifugation at 16 000 g for 45 min, dried in a lyophilizer and stored at -20 °C until ready for use. Nucleic acids from fraction 3A were washed with alcohol before the transfection to avoid interference of salt residues with the CaC12 precipitation or with the osmolarity of the cell culture. This nucleic acid was resuspended in HEPES-buffered saline (HeBs) and divided into four batches: (i) an aliquot was heated in boiling water for 3 min to denature the DNA and it was called high mol. wt., single-stranded (HMW-SS); (ii) an aliquot was sonicated at 50 W at 0 °C with a Branson ultrasonic sonicator for 30 s to convert it to low mol. wt., double-stranded (LMW-DS); (iii) an aliquot of (ii) was heated in boiling water for 3 min to denature it to low mol. wt. single-stranded (LMW-SS); and (iv) an aliquot of high mol. wt. double-stranded (HMW-DS) received no treatment.
The normal mouse DNA used as a carrier was obtained from the brains of NIH Swiss-Webster mice sacrificed by neck fracture. Homogenization was accomplished with a glass tissue homogenizer at 4 °C in 0.3 M-NaC1, 0-01 M-EDTA pH 7.2 buffer (1 g/t0 vol.); nucleic acid extraction procedure was as the one described for series A. To obtain the DNA, pellets were resuspended in 0-01 M-NaC1 (1/10 of the original volume), and incubated with RNase A + T1 (100/~g/ml, 15 units/ml) for 3 h at 37 °C; after raising the salt to 0-3 M, it was followed by treatment with 1% SDS, proteinase K (100 ltg/ml) for 30 min at 60 °C, and one phenol-chloroform and two chloroform extractions before alcohol precipitation. ( Graham & van der Eb, 1973; and Stow & Wilke (1976) . Each of the different batches was made to two concentrations of 25/~g/ml and 70/2g/ml in HeBs and precipitated with 0.13 M-CaCI~ for 30 min at room temperature. Just prior to infection, 72-h cultures of foetal mouse brain cells were washed twice with HeBs, and 0.2 mt of the precipitated nucleic acid was added to each 35 mm dish. After adsorption for 40 min at 36 °C, 2 ml MEM 5/5, 0.6% glucose was added. Following an additional 4 h incubation, cells were washed twice and treated with 20% dimethyl sulphoxide (DMSO) (Sequonal grade) for 3 to 4 min, after which the cells were washed twice with HeBs and incubated with fresh media for 5 to 6 days. Another set of cells was transfected omitting the DMSO treatment to avoid possible toxicity of neurons by DMSO. Five to six days after transfection, supernatants from all the dishes were collected and saved. The cells were washed twice with PBS and treated with 0.3 ml/dish of 0.5% trypsin for 5 min at 37 °C, followed by 2 ml MEM 10% FCS and collected by centrifugation. The cells were resuspended in 0.3 ml of the saved supernatant, and 0.03 ml were inoculated into C57B1/6 mice by the i.c. route. From the time of harvest to the time of inoculation (between 1 and 3.5 h) cells were held at 36 °C. Six female mice were inoculated with each different cell preparation.
Transfection of foetal brain cells series

Transfection of whole mouse embryo cells, series B.
The alcohol-precipitated fractions F(4B) and F(5B) were used to transfect secondary whole mouse embryo cells by the same calcium precipitation procedure. Nucleic acid from scrapie-infected brain at a concentration of 25/lg/ml was precipitated with 0.13 M-CaC12 and the light floculant precipitate from 3 ml nucleic acid solutions was placed on a 75 cm 2 flask of cells. Three different cell types were used: NIH Swiss-Webster, Balb/c and C 57B1/6. Following the transfection, each cell line was cultured for 1 week with one transfer, and the cells harvested and injected i.c. into NIH Swiss-Webster mice.
Another approach to promoting the uptake of the nucleic acid was the use of DEAE-dextran treatment of the cells to promote phagocytosis (Sheldrick et al., 1973) . The nucleic acid was mixed with 200/~g/ml DEAE-dextran and placed on the cells in the same ratio as described for the calcium-precipitated material. Following 1 week of incubation with one cell transfer, the infectivity was assayed by the i.c. inoculation of NIH Swiss-Webster mice.
RESULTS
Recovery of infectivity in serapie brain homogenate
In order to estimate the loss of biological activity during phenol extraction of scrapie-infected brain, bacteriophage ~X174 was used as an internal marker during the extraction procedure. Since ~X174 is a circular ssDNA molecule, a single nick in its DNA will destroy the infectivity. To test the physical integrity and biological activity during the extraction procedure, 2.5 x 10 ~a p.f.u, of ~X174 were added to 1 ml of 10% homogenate of scrapie-infected brain prior to extraction. A total of 150/~g nucleic acid was obtained from the extraction and the infectivity of the ~X 174 DNA was determined by spheroplast assay on KT-3. To correct for the effect of the presence of eukaryotic DNA on the efficiency of the spheroplast assay, we compared its efficiency against a separate assay of DNA obtained by extracting together 2.5 x 1011 ~X174 p.f.u, mixed with 150 ~g normal mouse DNA. This comparison gives the maximum possible loss of infectivity, because ~X174 virus was mixed with purified normal mouse DNA instead of whole brain homogenate, and the nucleic acids from this preparation'would contain RNA which possibly interferes differently with the spheroplast assay.
The infectious centre titre of spheroplast assay of #X174 when mixed with normal mouse brain DNA was 6.6 x 106 or an efficiency of 2.6 x 10 -5. In the case of the ~X174 DNA extracted with scrapie-infected brain, the titre was 3-2 x 105, which represents a recovery of 1.3 x 10 -6 of the input infectivity. Infectious DNA was recovered during the scrapie nucleic acid extraction with a loss of only 1.3 log10. No plaques were formed when the DNA at the lowest dilution was assayed directly on the indicator bacteria indicating no free phage were present in any of the preparations following phenol extraction.
Recovery of virus particles from transfeeting foetal mouse brain cells with herpes virus DNA
To prove that the transfection procedure was working and that the DNA was in fact entering the brain cells and replicating inside them, the DNA of a well-characterized virus, HSV, was used as a transfection control. Two of the foetal mouse brain cultures were infected with herpes DNA, and the formation of virus particles was assayed on SRK cells. Herpes DNA was precipitated and transfected by the same procedure as that of the nucleic acid extracted from scraple-infected mouse brains; each 35 mm dish was infected with 0.25 ml containing 25/~g/ml DNA (0.2 #g HSV DNA plus 6.25 ~g/normal mouse brain DNA as a carrier). Five days after transfection, the brain cell cultures did not show any cytopathic changes. At this time, the cells (collected as indicated earlier in Methods for series A experiments), were sonicated and both cells and supernatants were assayed independently; virus particles were present both in the supernatant and intracellularly 5 days after transfection and the number of herpes virus particles inside the cells was 15 times higher than in the supernatant. The total number of HSV plaques that were produced in the brain culture (cells plus supernatant) in response to transfection was 9-8 x 101/0.2/~g HSV DNA. Thus, herpes infection with a purified HSV nucleic acid did occur in the foetal brain cells. Transfection efficiency was not possible to measure due to the absence of c.p.e, in the brain culture. Nevertheless, assuming a mol. wt. of 1 x 108 for HSV DNA (Kieffet al., 1971 ) and a plating efficiency of 1 x 10 -1, then 1.2 x 109 HSV molecules produce 9.8 x 10 4 virus particles, which subsequently will be available to inoculate the animals. Plates transfected with 0.2/~g herpes DNA mixed with carrier to give a final concentration of 70/~g/ml gave no HSV plaques, indicating that increased DNA concentration drastically lowers the efficiency of transfection. 
Biological activity of scrapie nucleic acids
The various steps during the nucleic acid extraction were monitored for infectivity by the inoculation of mice i.c.; the titres of the various fractions are summarized in Table 1 . It is clear that infectious virus was not detectable following extraction with phenol and treatment with SDS. Furthermore, there was no evidence of infectious virus being trapped in the interface of the phenol extraction.
One possible means of enhancing the infectivity and protecting the nucleic acid is to transfect cultured cells in vitro and then place the cells into the experimental host. In order to examine the greatest number of possibilities, different approaches were taken when transfecting nucleic acids obtained from series A and B experiments. To increase the amount of scrapie-specific nucleic acid going into the cell, the nucleic acid concentrations used in these transfection experiments are slightly higher than the one given by Graham (10 gg/ml) as an optimal DNA concentration for transfection efficiency (Graham & van der Eb, 1973) . The 20 different conditions studied are summarized in Table 2 . On series A, a transfection control with a normal brain nucleic acid was included; none of the transfected cell cultures induced scrapie following injection into isologous hosts. On series B, no infectivity was found after transfecting embryonic cell cultures prepared from NIH Swiss-Webster, Balb/c and C57B1/6 mice employing the fractions obtained from the two procedures described. Following 18 months incubation, there was still no sign of disease in mice inoculated with these materials and histopathological examination of their brains failed to elicit evidence of spongiform encephalopathy.
DISCUSSION
Attempts to demonstrate an infectious nucleic acid in scrapie-infected tissue have always been compromised by the potential problem of inactivation of the nucleic acid during extraction or in the brain of the animals used for assay of the virus. To minimize nucleic acid degradation we used proteinase K on series A and heat inactivation on series B; proteinase K has been proven to be a powerful endoprotease that inactivates nucleases very quickly without damaging the DNA or RNA (Faust et al., 1973; Hansen, 1974) ; a heat inactivation step has been used successfully for Col E2 plasmid extraction for its ability to degrade the plasmid-bound protein without introducing any nicks on the closed circular DNA (Blair et aL, 1971) .
The experiments reported here have tried to control both of those factors using biologically active markers during the extraction and incorporating in vitro transfection prior to injecting the material into an animal. Appropriate controls could not be chosen since the molecular nature of the scrapie virus is unknown; thus, control viruses were used whose requisites for infectivity recovery and transfection were to be more stringent than scrapie. In the case of ~X174, one single nick is enough to destroy its infectivity. HSV DNA is approx. 1000 times the estimated size of scrapie genome (mol. wt. estimated to be 1.5 x 105 to 0.6 × 105; Alper et al., 1966; Latarjet, 1979) ; since the transfection procedures are based on the ability of the nucleic acid to easily penetrate the ceil, it seems logical to think that scrapie nucleic acid would enter more readily. Although it was shown that biological activity of the ~X174 virus comes through the extraction procedure employed and the brain cell cultures were capable of being transfected, nucleic acid from highly infectious scrapie tissues still proved noninfectious.
Possible causes of these negative results are" (i) the nucleic acid or its infectivity was lost during the extraction procedure; (ii) not enough scrapie nucleic acid entered the cells; (iii) scrapie nucleic acid alone is not infectious and an additional scrapie-specific associated protein may be needed for scrapie multiplication; (iv) there is no nucleic acid in scrapie. The first possibility is unlikely. Loss of scrapie nucleic acid would be due to a binding of the agent to the proteins and lipids of the cell, causing the trapping of the nucleic acid into the phenol-chloroform phase or interface. The salt and pH conditions used (0.1 M-NaC1, 0.01 M-tris-HC1 pH 7.4), the treatment with proteinase K at high temperature, the presence of SDS and chloroform, and the repeated reextraction of the interface, make the specific loss of any nucleic acid present in the cell unlikely. No nucleic acid is known to be lost specifically after such treatment. Virus nucleic acids with a known covalently bound protein (Lee et al., 1977) are recovered in the aqueous phase of the extraction; OX 174, the bacteriophage used as a control, is thought to have a protein covalently bound to its genome. There is no evidence that the total disappearance of scrapie infectivity after phenol-chloroform treatment is due to the partitioning of the infectivity into a discarded fraction of the preparation. Nor is the loss due to the rupture of the physical integrity of the nucleic acid. A bioassay of the interface done with fraction F(3B) produced no scrapie infectivity. On the other hand, the virus used as a control, ~X174, mixed with a DNase-rich scrapie homogenate, lost only 1.3 logs of infectivity. This indicates that breakage of the nucleic acid does not seem to be the cause of the loss of the total infectivity of the scrapie homogenate.
If there was no loss or damage to the scrapie nucleic acid, why was it not able to transfect? In Table 3 we speculate about the number of putative equivalent infectious molecules (ELM) inoculated per animal; the calculation was based on the measured titre of the clarified scrapie brain homogenate prior to the extractions; thus, each ElM represents the number of molecules (_> 1) in one infectious unit. The use of the efficiency of the recovery of the virus control ~X174 gives us the minimal number of infectious molecules able to induce scrapie in animals (2 × 105 to 6 × 105); this is because ~X174 genome contains one DNA molecule, while more may be needed for scrapie infectivity (two molecules could be degraded, but only one infectious unit lost). The fact that the animals inoculated with at least 2 × l0 s to 6 × l0 s did not develop the disease clearly differentiates scrapie from the plant viroids of Diener Table 3 , 2 x 105 to 6 x 105, we calculate that 16 to 48 is the possible number of scrapie infective units inoculated into a single animal; that should be sufficient to induce disease.
The reason for failure to recover infectious scrapie-specific nucleic acid remains unknown. Transfection in vitro prior to inoculation eliminates the need for a protein required for adsorption: nucleic acid enters the cell and still is not able to replicate. Perhaps what is needed may not be penetration into the cell or protection before inoculating the animal, but instead a specific scrapie-associated protein that is necessary to initiate replication or transcription. The nucleic acid from such a virus will always result in a negative transfection; neither the control EMC virus used by Marsh et al. (1974) nor the HSV virus used in these experiments requires an essential starting protein; both are viruses that use host enzymes as the first step in multiplication.
The non-nucleic acid scrapie theory has been suggested since 1959 from several authors based on different properties (Stamp et al., 1959; Field, 1966; Alper et al., 1966 Alper et al., , 1967 Alper et al., , 1978 Gibbons & Hunter, 1967) . Although, at present, it is difficult to conceive a replicating molecule other than a nucleic acid, the possibility of new forms of replication must remain open.
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